StonvexLoading…
StonvexStonvexStonvexCore line items from CLX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 | Annual 2022 2022-06-30 |
|---|---|---|---|---|
Revenue | $7.10B | $7.09B | $7.39B | $7.11B |
Operating Income | $1.08B | $398.00M | $238.00M | $607.00M |
Net Income | $810.00M | $280.00M | $149.00M | $462.00M |
EPS (Diluted) | $6.52 | $2.25 | $1.20 | $3.73 |
Total Assets | $5.56B | $5.75B | $5.95B | $6.16B |
Total Liabilities | $5.08B | $5.26B | $5.56B | $5.43B |
Cash & Equivalents | $167.00M | $202.00M | $367.00M | $183.00M |
Free Cash Flow OCF − CapEx | $761.00M | $483.00M | $930.00M | $535.00M |
Shares Outstanding | 122.69M | 124.20M | 123.82M | 123.15M |